| P50 | author | Paula K Shireman | Q85030618 |
| P2093 | author name string | H C Kwaan | |
| | W H Pearce | |
| | W J McCarthy | |
| | M Cipollone | |
| | P K Shireman | |
| | V P Shively | |
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| | Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells | Q34621520 |
| | The role of plasminogen activators in the regulation of connective tissue metalloproteinases | Q35240608 |
| | Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion | Q35751580 |
| | Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas | Q35977650 |
| | Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells | Q36217171 |
| | Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. | Q36552106 |
| | Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries | Q37131350 |
| | Biochemical and biological aspects of the plasminogen activation system | Q37942218 |
| | Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium. | Q53472485 |
| | Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta. | Q54420587 |
| | Plasminogen activator and plasminogen activator inhibitor activities in a reference population | Q68093637 |
| | Metalloproteinases in degenerative aortic disease | Q68253101 |
| | Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery | Q68339861 |
| | Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 |
| | Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis | Q70330793 |
| | Relationship between age and plasma t-PA, PA-inhibitor, and PA activity | Q70357338 |
| | Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease | Q72045113 |
| | Regulation of plasminogen activator production by cultured endothelial cells | Q72066921 |
| | Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study | Q72192287 |
| | Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma | Q72253840 |
| | Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease | Q72390494 |
| | In vivo demonstration of focal fibrinolytic activity in abdominal aortic aneurysms | Q72679320 |
| | Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke | Q72773126 |
| P433 | issue | 1 | |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 157-164 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Journal of Vascular Surgery | Q15755733 |
| P1476 | title | Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta | |
| P478 | volume | 25 | |